Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBIAT (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of EBIAT data on record, last reported at -$1.9 million in Q4 2012.

  • For Q4 2012, EBIAT rose 24.93% year-over-year to -$1.9 million; the TTM value through Dec 2012 reached -$4.8 million, up 34.47%, while the annual FY2012 figure was -$7.3 million, 7.79% up from the prior year.
  • EBIAT reached -$1.9 million in Q4 2012 per SNOA's latest filing, down from -$1.5 million in the prior quarter.
  • Across five years, EBIAT topped out at $445000.0 in Q2 2012 and bottomed at -$2.5 million in Q4 2011.
  • Average EBIAT over 3 years is -$1.7 million, with a median of -$1.8 million recorded in 2012.
  • The widest YoY moves for EBIAT: up 120.46% in 2012, down 81.05% in 2012.
  • A 3-year view of EBIAT shows it stood at -$2.2 million in 2010, then decreased by 14.22% to -$2.5 million in 2011, then rose by 24.93% to -$1.9 million in 2012.
  • Per Business Quant database, its latest 3 readings for EBIAT were -$1.9 million in Q4 2012, -$1.5 million in Q3 2012, and $445000.0 in Q2 2012.